JDLA
EW icon

J. Derek Lewis & Associates’s Edwards Lifesciences EW Stock Holding History

J. Derek Lewis & Associates’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$804K Sell
8,890
-400
-4% -$33.5K 0.15% 87
2026
Q1 		$744K Buy
9,290
+5,499
+145% +$453K 0.17% 78
2025
Q4 		$323K Buy
+3,791
New +$311K 0.08% 131

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

J. Derek Lewis & Associates's EW Position: Q2 2026 in Review

J. Derek Lewis & Associates reduced its Edwards Lifesciences (EW) stake by 4.3% in Q2 2026, selling an estimated $33.5K and leaving 8,890 shares worth $804K. The position accounts for 0.15% of the portfolio, ranked #87.

J. Derek Lewis & Associates first reported a position in EW in Q4 2025 and has held it in 3 quarters since. 774 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • J. Derek Lewis & Associates held 8,890 shares of Edwards Lifesciences worth $804K as of Q2 2026.
  • J. Derek Lewis & Associates sold 400 Edwards Lifesciences shares in Q2 2026, an estimated $33.5K.
  • Edwards Lifesciences made up 0.15% of J. Derek Lewis & Associates's portfolio in Q2 2026, its #87 holding.
  • J. Derek Lewis & Associates first reported a position in Edwards Lifesciences in Q4 2025 and has held it in 3 quarters since.
  • 774 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on J. Derek Lewis & Associates's 13F filing for Q2 2026, filed 31 Jul 2026.